WHO enrolls Spain and Norway for COVID-19 initial Clinical trial

Clinical Research |  News | 0 Comment | 28 Mar, 2020

"Spain and Norway are ready to enrol their patients for COVID-19 clinical trial", announces Dr Tedros Adhanom Ghebreyesus, Director-General of WHO, on 27 March 2020 regarding the first...Read more

Novotech nominated for Citeline Award for being excellent APAC CRO

Clinical Research |  News | 0 Comment | 23 Mar, 2020

Asia-Pacific's largest specialist biotech CRO Novotech has been selected as a finalist in two categories for the Citeline Awards 2020 (formerly CARE Awards), hosted by Informa Pharma Intell...Read more

Avance Clinical to deliver rapid results for urgent COVID-19 trials

Clinical Research |  News | 0 Comment | 20 Mar, 2020

Australian CRO Avance Clinical has said that Australia’s fast regulatory approval environment, key opinion leader expertise and high-quality clinical research sites, as well as the at...Read more

Molecular docking show SARS-CoV-2 inhibition by Linebacker & Equivir

Clinical Research |  News | 0 Comment | 18 Mar, 2020

SGX-listed Singapore eDevelopment Ltd has announced that its wholly-owned U.S. biomedical subsidiary Impact BioMedical, Inc. has through its scientific research partner GRDG Sciences, LLC. ...Read more

New GeoMap Tools Gets Patient Recruitment Back on Track

Clinical Research |  News | 0 Comment | 11 Mar, 2020

Award-winning global leader in digital patient recruitment GeoMap Clinical by TrialWire announced on 11 March 2020 that new tools added to the GeoMap geo-targeting Platform that can restore...Read more

Novotech Wins CRO Contract for Covid-19 Clinical Trial in South Korea

Clinical Research |  News | 0 Comment | 09 Mar, 2020

Asia-Pacific’s largest specialist biotech CRO Novotech has been selected for the Komipharm International clinical trials of Panaphix as a potential treatment for coronavirus &nda...Read more

WuXi Biologics congratulates Immutep on positive interim data for IMP-321

Clinical Research |  News | 0 Comment | 24 Feb, 2020

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its st...Read more

AVROBIO announces clinical and regulatory progress for Gaucher Disease Program

Clinical Research |  News | 0 Comment | 17 Jan, 2020

US based AVROBIO, a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, has received notice of clearance from the U.S. Food and Dru...Read more

PPD expands clinical capabilities in China

Clinical Research |  News | 0 Comment | 15 Jan, 2020

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chinese biopharmaceutical companies with more Comprehensive clinical deve...Read more

Genome & Company inks clinical trial collaboration

Clinical Research |  News | 0 Comment | 15 Jan, 2020

Genome & Company, a clinical-stage biotechnology company based in Seongnam, Republic of Korea, has announced that it has entered into a clinical trial collaboration and supply agre...Read more

Hummingbird Publishes Preclinical efficacy of HMBD-001 in HER3 driven Cancers

Clinical Research |  News | 0 Comment | 08 Jan, 2020

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery and development of new breakthrough precision antibody therapeutics for difficult-to-treat conditions,...Read more

CStone initiates CS1001 trial to treat ESCC in China

Clinical Research |  News | 0 Comment | 08 Jan, 2020

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as fir...Read more

Transgene, NEC initiate trials with AI-Powered Cancer Vaccine

Clinical Research |  News | 0 Comment | 07 Jan, 2020

French firm Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and Japan based NEC Corporation, a leader in IT and network techn...Read more

Eisai presented research data on Eribulin (Halaven) at 42nd Annual SABCS2019

Clinical Research |  News | 0 Comment | 16 Dec, 2019

Eisai Co., Ltd. presented its latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "...Read more

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference

Clinical Research |  News | 0 Comment | 31 Dec, 2019

Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences in San Francisco, California at the...Read more

Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer

Clinical Research |  News | 0 Comment | 18 Dec, 2019

Liver cancer is the fourth most common cancer among men and affects approximately 24 individuals in every 100,000 people a year. Globally, it is the fourth leading cause of cancer-related d...Read more

NeuClone announces Positive Ph I results of Herceptin® (Trastuzumab) Biosimilar

Clinical Research |  News | 0 Comment | 13 Dec, 2019

NeuClone Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, on 5 Dec 2019, announced that NeuCeptin, a biosi...Read more

Takeda presents Phase III Trial results in patients with amyloidosis

Clinical Research |  News | 0 Comment | 09 Dec, 2019

Japan based Takeda Pharmaceutical Company Limited announced the presentation of the results of tourmaline-AL1 trial in an oral session at the 61 to annual meeting of the American ...Read more